QC
BMY icon

Quantessence Capital’s Bristol-Myers Squibb BMY Stock Holding History

Quantessence Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553K Buy
+9,119
New +$532K 2.69% 11
2025
Q2 		– Sell
-37,100
Closed -$2.26M – 213
2025
Q1 		$2.26M Buy
+37,100
New +$2.16M 0.57% 35

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantessence Capital's BMY Position: Q1 2026 in Review

Quantessence Capital opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 9,119 shares worth $553K. The stake represents 2.69% of the portfolio and ranks #11 among its holdings. This is a return to the name: Quantessence Capital previously reported a position in BMY as recently as Q1 2025.

Quantessence Capital first reported a position in BMY in Q1 2025 and has held it in 2 quarters since. The position peaked at $2.26M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Quantessence Capital held 9,119 shares of Bristol-Myers Squibb worth $553K as of Q1 2026.
  • Bristol-Myers Squibb was a new Quantessence Capital position in Q1 2026.
  • Bristol-Myers Squibb made up 2.69% of Quantessence Capital's portfolio in Q1 2026, its #11 holding.
  • Quantessence Capital first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 2 quarters since.
  • Quantessence Capital's Bristol-Myers Squibb position peaked at $2.26M in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Quantessence Capital's 13F filing for Q1 2026, filed 15 May 2026.